Schizophrenia Bulletin Advance Access published online on October 27, 2005
Schizophrenia Bulletin, doi:10.1093/schbul/sbj013
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
* To whom correspondence should be addressed. This review examines the structural validity of negative symptoms focusing on 2 questions: (1) Do negative symptoms represent a domain separate from other symptoms in schizophrenia? and (2) Within negative symptoms, is there a structure that suggests multidimensionality? Results from exploratory and confirmatory factor analytic studies are examined to address these questions. Across studies and symptom instruments, negative symptoms appear to consistently emerge as a factor separate from other dimensions of the illness in schizophrenia. Whether 2-, 3-, or 5-factor models are identified, negative symptoms consistently load on a factor separate from positive symptoms, affective symptoms of depression or anxiety, and symptoms of disorganization. Focusing on negative symptoms themselves, factor analytic findings suggest that this construct is multidimensional with at least 2 factors (involving diminished expression and anhedonia-asociality). Although these factors were replicable, serious limitations were noted in this literature. Thus, 2- (or even 3- or 5-) factor models of negative symptoms should not be considered definitive, but rather all converge to support the general conclusion of the multidimensionality of negative symptoms. The later findings indicate the importance of employing assessments that provide adequate coverage of the broad domain of negative symptoms. Importantly, caution is noted in the interpretability of findings based on existing instruments, and implications for future assessment are discussed.
Article
The Structure of Negative Symptoms Within Schizophrenia: Implications for Assessment
1 Department of Psychology, University of Maryland, College Park
Jack J. Blanchard, E-mail: jblanchard{at}psyc.umd.edu
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. M. Gold, J. A. Waltz, K. J. Prentice, S. E. Morris, and E. A. Heerey Reward Processing in Schizophrenia: A Deficit in the Representation of Value Schizophr Bull, September 1, 2008; 34(5): 835 - 847. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Foussias and G. Remington Negative Symptoms in Schizophrenia: Avolition and Occam's Razor Schizophr Bull, July 21, 2008; (2008) sbn094v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Cohen and K. S. Minor Emotional Experience in Patients With Schizophrenia Revisited: Meta-analysis of Laboratory Studies Schizophr Bull, June 17, 2008; (2008) sbn061v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kotov, L. T. Guey, E. J. Bromet, and J. E. Schwartz Smoking in Schizophrenia: Diagnostic Specificity, Symptom Correlates, and Illness Severity Schizophr Bull, June 17, 2008; (2008) sbn066v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Pfeifer, J. van Os, M. Hanssen, P. Delespaul, and L. Krabbendam Subjective Experience of Cognitive Failures as Possible Risk Factor for Negative Symptoms of Psychosis in the General Population Schizophr Bull, February 21, 2008; (2008) sbn004v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Roy, J. C. Murtie, B. F. El-Khodor, N. Edgar, S. P. Sardi, B. M. Hooks, M. Benoit-Marand, C. Chen, H. Moore, P. O'Donnell, et al. Loss of erbB signaling in oligodendrocytes alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disorders PNAS, May 8, 2007; 104(19): 8131 - 8136. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Halari, R. Mehrotra, T. Sharma, and V. Kumari Does Self-perceived Mood Predict More Variance in Cognitive Performance Than Clinician-Rated Symptoms in Schizophrenia? Schizophr Bull, October 1, 2006; 32(4): 751 - 757. [Abstract] [Full Text] [PDF] |
||||

